The use of the BCT in the population included in the EORTC22922/10925 investigating elective lymph node irradiation comparing with 22881/10882 investigating the role of a boost in early breast cancer

E.Musat; Poortmans; H.Bartelink; W.Van den Bogaert; J.C.Horiot; H.Struikmans; A.Fourquet; C.Kirkove; M.Pierart; L.Collete

首页> 外文期刊>European Journal of Cancer Supplements >The use of the BCT in the population included in the EORTC22922/10925 investigating elective lymph node irradiation comparing with 22881/10882 investigating the role of a boost in early breast cancer

【24h】

The use of the BCT in the population included in the EORTC22922/10925 investigating elective lymph node irradiation comparing with 22881/10882 investigating the role of a boost in early breast cancer

机译：在EORTC22922 / 10925调查选择性淋巴结放疗的人群中，BCT的使用与22881/10882调查增强对早期乳腺癌的作用的人群相比，BCT的使用

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第2期|共1页
作者
E.Musat; Poortmans; H.Bartelink; W.Van den Bogaert; J.C.Horiot; H.Struikmans; A.Fourquet; C.Kirkove; M.Pierart; L.Collete;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. [J] . Poortmans PM, Collette L, Bartelink H, Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique . 2008,第6a7期

机译：保留乳房的乳腺癌治疗后，在肿块切除术后在原发肿瘤床上增加剂量。 EORTC 22881-10882“增强与无增强”试验结果的摘要。
2. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. [J] . Collette S, Collette L, Budiharto T, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2008,第17期

机译：早期乳腺癌的保乳治疗后10年纤维化风险的预测指标：一项基于EORTC试验22881-10882“增强与无增强”的研究。
3. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. [J] . Bartelink H, Horiot JC, Poortmans PM, Journal of Clinical Oncology . 2007,第22期

机译：早期乳腺癌的保乳治疗中较高的辐射剂量对局部控制和生存的影响：随机加强与无加强EORTC 22881-10882试验的10年结果。
4. Investigation of Lymph Node Metastases by Clearing Method Supports Pelvic Plexus Preservation in Rectal Cancer Surgery [C] . J. Hida, T. Yoshifuji, F. Sugiura, International Society of University Colon and Rectal Surgeons . 2008

机译：清除方法对淋巴结转移的研究支持直肠癌手术中的骨盆丛保存
5. Energy balance, risk of breast cancer, and prognosis after breast cancer: Investigating the complex roles of diet and physical activity. [D] . George, Stephanie Ambrogi Materese. 2010

机译：能量平衡，乳腺癌风险和乳腺癌后的预后：研究饮食和身体活动的复杂作用。
6. Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05) [O] . J M Noh, W Park, C-O Suh, 2014

机译：对于II期至III期乳腺癌的新辅助化疗和保乳手术选择性淋巴结照射对病理阴性的淋巴结患者是否有益？多中心回顾性研究（KROG 12-05）
7. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage i to III breast cancer (EORTC trial 22922/10925) [O] . Matzinger, O., Heimsoth, I., Poortmans, P., 2010

机译：一期至三期乳腺癌在有或没有接受内乳及内侧锁骨上淋巴结链照射下的三年毒性（EORTC试验22922/10925）

The use of the BCT in the population included in the EORTC22922/10925 investigating elective lymph node irradiation comparing with 22881/10882 investigating the role of a boost in early breast cancer

著录项

相似文献

相关主题

期刊订阅